News
Ultimovacs ASA Initiates FOCUS Phase II Trial for Universal Cancer Vaccine, UV1, in Head and Neck Cancer Patients Receiving Pembrolizumab
Ultimovacs ASA ("Ultimovacs", ticker ULTI), today announced the initiation of FOCUS, a Phase II randomized clinical trial that will evaluate the Company’s proprietary universal cancer vaccine, UV1,
MedMen Appoints Reece Fulgham as Interim Chief Financial Officer
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the United States, today named Reece Fulgham as Interim Chief
Nutrien Announces Agreement for Sale of Equity Position in MOPCO and Settlement of All Arbitration Claims
Nutrien Ltd. (NYSE, TSX: NTR)(“Nutrien”) announced today that, through one of its wholly-owned subsidiaries, it has entered into an agreement with the Government of Egypt (through the Egyptian
Cloudflare kündigt Cloudflare Pages an und stellt Unternehmen und Entwicklern die nächste Generation der Website-Entwicklungsplattform zur Verfügung
Cloudflare, Inc. (NYSE: NET), das Unternehmen für Sicherheit, Performance und Zuverlässigkeit für ein besseres Internet, kündigte heute die Veröffentlichung von Cloudflare Pages an, der
CURO Group Holdings Corp. Positioned to Benefit from Katapult’s Announced Merger with FinServ Acquisition Corp.
CURO Group Holdings Corp. (NYSE: CURO) (“CURO”), a market leader in providing credit to non-prime consumers, announced today that it is positioned to benefit from today’s announcement that Katapult
Tufin Expands Security Policy Platform with Enriched Risk Assessment Data to Deliver Superior Security
Tufin® (NYSE: TUFN), a company pioneering a policy-centric approach to security and IT operations, today announced the release of Tufin Orchestration Suite R20-2, integrating network security
Covid-19: MedinCell Presents Positive First Results From the Clinical Trial Aiming at Validating the Safety of Continuous Administration of Ivermectin
MedinCell (Paris:MEDCL):
Study’s first results presented at the international “Collaborative Workshop – Ivermectin against Covid-19” held on December 15, 16 and 17 at the initiative of MedinCell
Cloudflare Announces Cloudflare Pages, Brings Next Generation Website Development Platform to Businesses and Developers
Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet, today announced the release of Cloudflare Pages, the next-generation website
Andere Ansichten zur enormen Unterbewertung von ABO Wind
MedMen Announces Tom Lynch Elected as Chairman of the Board
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the United States, today announced that Tom Lynch has been elected
So tickt die Börse: Die (Aktien-)Welt von Übermorgen
Blackline Safety launches G7c close contact detection for North America and international markets
Blackline Safety Corp. (TSX.V: BLN), a global leader of gas detection and connected safety solutions, has expanded the availability of its new G7 close contact detection firmware to North American
Tufin Announces Support for Google Cloud Platform
Tufin® (NYSE: TUFN), a company pioneering a policy-centric approach to security and IT operations, today announced that Tufin SecureCloud™ now supports the Google Cloud Platform, allowing customers
GrafTech Announces Upsizing and Pricing of Secondary Offering of Common Stock by Existing Stockholders
GrafTech International Ltd. (NYSE: EAF) (“GrafTech” or the “Company”) today announced that affiliates of Brookfield Asset Management Inc. and Brookfield Business Partners LP, members of the
GrafTech Announces Secondary Offering of Common Stock by Existing Stockholders
GrafTech International Ltd. (NYSE: EAF) (“GrafTech” or the “Company”) today announced that affiliates of Brookfield Asset Management Inc. and Brookfield Business Partners LP, members of the
GSE Wins Two Master Services Agreements Worth $35 Million with Major US Utility for Contract Workforce Support
GSE Systems, Inc. (“GSE Solutions” or “GSE”) (Nasdaq: GVP), a leader in delivering end-to-end training, engineering, compliance, simulation, and workforce solutions to the power industry, today
DONTNOD ENTERTAINMENT : TELL ME WHY(TM) AWARDED AT THE 2020 GAME AWARDS
December 14, 2020. DONTNOD Entertainment, French independent video game creation and development studio, is proud to announce that Tell Me WhyTM has once again been awarded, this time at the 2020
Nutrien Declares Quarterly Dividend of US$0.45 per Share
Nutrien Ltd (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.45 per share payable January 14, 2021 to shareholders of record on December 31
Tufin Announces Partner of the Year Award Winners
Tufin® (NYSE: TUFN), a company pioneering a policy-centric approach to security and IT operations, today announced the winners of its annual Partner of the Year awards. During the Tufinnovate User
The NAGA Group AG: Wachstum hält an, Rekord-Transaktionen und Volumen im lfd. Q4. Hauck & Aufhäuser nimmt Coverage auf und stuft NAGA mit dem Rating 'KAUFEN' und einem Kursziel von EUR 5,90 ein.
Die NAGA GROUP (XETRA: N4G, ISIN: DE000A161NR7), Anbieter des sozialen Netzwerks für den Finanzmarkthandel NAGA.com, berichtet von einem anhaltenden Wachstum auf hohem Niveau in den Monaten Oktober
The NAGA Group AG: Growth path continues, record transactions and volumes in the current Q4. Hauck & Aufhäuser starts coverage and gives NAGA a 'BUY' rating and a target price of EUR 5.90.
The NAGA GROUP (XETRA: N4G, ISIN: DE000A161NR7), provider of the social network for financial market trading NAGA.com, reports sustained growth at a high level in the months of October and November
AVIO Signs Contract With ESA For the Development of the Space Rider System
AVIO and Thales Alenia Space (Thales 67%, Leonardo 33%) as co-contractor, signed a contract with the European Space Agency (ESA) for the development of the automated reusable Space Rider
Ultimovacs Announces Positive 5-Year Overall Survival Update from Phase I Combination Trial Evaluating Universal Cancer Vaccine UV1 in Metastatic Melanoma
Ultimovacs ASA ("Ultimovacs", ticker ULTI), today announced positive five-year Overall Survival (OS) data from the Phase I trial evaluating the company’s universal cancer vaccine, UV1, in
Columbia Care Statement on Boston Zoning Board of Appeal Approval for Adult-Use Designation at Downtown Boston Dispensary
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) is excited and thankful to receive approval from the Boston Zoning Board of Appeal for its
Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell therapies for serious medical conditions, today announced that